Literature DB >> 6390359

Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP).

B E Dunning, J H Moltz, C P Fawcett.   

Abstract

Marked stimulation of glucagon release and modest stimulation of insulin release were observed during in situ perfusion of the rat pancreas with AVP or OT. Glucagon release in response to AVP or OT (200 pg/ml) gradually increased over a 45 min perfusion period reaching maxima of 500% and 300% of the pre-stimulatory levels, respectively. Insulin release transiently increased by 100%. In each case release rates returned to control values immediately after withdrawal of the peptides. Total glucagon release was concentration dependent and linear from 20 pg to 20 ng AVP or OT/ml (r greater than .97). Pancreatic response to DDAVP perfused at 20 ng/ml was virtually indistinguishable from that induced by AVP at 200 pg/ml. This demonstration of a glucagonotrophic action of the neurohypophysial hormones in the in situ perfused rat pancreas confirms earlier studies using isolated islets and bolus IV injection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6390359     DOI: 10.1016/0196-9781(84)90109-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

1.  Mechanisms of AVP-induced glucagon release in clonal alpha-cells in-R1-G9: involvement of Ca(2+)-dependent and -independent pathways.

Authors:  S Yibchok-Anun; H Cheng; T H Chen; W H Hsu
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Insulin hypersensitivity in mice lacking the V1b vasopressin receptor.

Authors:  Yoko Fujiwara; Masami Hiroyama; Atsushi Sanbe; Toshinori Aoyagi; Jun-Ichi Birumachi; Junji Yamauchi; Gozoh Tsujimoto; Akito Tanoue
Journal:  J Physiol       Date:  2007-08-02       Impact factor: 5.182

3.  Impaired glucose tolerance, glucagon, and insulin responses in mice lacking the loop diuretic-sensitive Nkcc2a transporter.

Authors:  Lisa Kelly; Mohammed M Almutairi; Shams Kursan; Romario Pacheco; Eduardo Dias-Junior; Hayo Castrop; Mauricio Di Fulvio
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

4.  Conformation and dynamics of 8-Arg-vasopressin in solution.

Authors:  Elke Haensele; Lee Banting; David C Whitley; Timothy Clark
Journal:  J Mol Model       Date:  2014-11-06       Impact factor: 1.810

Review 5.  Coming full circle: contributions of central and peripheral oxytocin actions to energy balance.

Authors:  Jacqueline M Ho; James E Blevins
Journal:  Endocrinology       Date:  2012-12-27       Impact factor: 4.736

6.  Mechanisms of the stimulation of insulin release by oxytocin in normal mouse islets.

Authors:  Z Y Gao; G Drews; J C Henquin
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

7.  Oxytocin-like immunoreactive nerves are associated with insulin-containing cells in pancreatic islets of anglerfish (Lophius americanus).

Authors:  J K McDonald; F Greiner; J G Wood; B D Noe
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

8.  Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.

Authors:  Umer Saleem; Mahyar Khaleghi; Nils G Morgenthaler; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

Review 9.  The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis.

Authors:  Elizabeth A Lawson; Pawel K Olszewski; Aron Weller; James E Blevins
Journal:  J Neuroendocrinol       Date:  2019-11-28       Impact factor: 3.627

10.  Arginine vasopressin: Direct and indirect action on metabolism.

Authors:  Mitsuhiro Yoshimura; Becky Conway-Campbell; Yoichi Ueta
Journal:  Peptides       Date:  2021-04-24       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.